Latest Breaking News On - Potentially pivotal study - Page 1 : comparemela.com

CNS Pharmaceuticals : Announces Successful Interim Analysis of Efficacy and Safety Data in Potentially Pivotal Study of Berubicin - Form 8-K -December 18, 2023 at 08:39 am EST

CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced.

United statesJohn climacoJenene thomasPharmaceuticals fast track designation for berubicinExchange commissionCompany on twitterSecurities exchangeReata pharmaceuticals incPharmaceuticals announces successful interim analysis of efficacyPharmaceuticals incUniversity of texas md anderson cancer centerAnnounces successful interim analysisSafety dataPotentially pivotal studyData safety monitoring boardOverall survival

CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Safety Data from

CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Safety Data from .

United statesBritish columbiaSandra silbermanSociety of neurooncologyReata pharmaceuticals incPharmaceuticals fast track designation for berubicinUniversity of texas md anderson cancer centerNews networkPharmaceuticals incCompany on twitterSecurities exchangePresents updated safety dataAnnual meetingGlioblastoma multiformeChief medical officerInterim results

CNS Pharmaceuticals, Inc : CNS Pharmaceuticals Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy

CNS Pharmaceuticals, Inc : CNS Pharmaceuticals Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Rheinland pfalzBritish columbiaUnited statesJenene thomasSandra silbermanPharmaceuticals incSecurities exchangePharmaceuticals fast track designation for berubicinReata pharmaceuticals incUniversity of texas md anderson cancer centerCompany on twitterSociety of neurooncologyExchange commissionPharmaceuticals inc viewGlioblastoma multiformeAnnual meeting

CNS Pharmaceuticals (CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy

CNS Pharmaceuticals (CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaSandra silbermanPharmaceuticals fast track designation for berubicinCns pharmaceuticals incAnnual meetingChief medical officerInterim resultsUpdated safety resultsPotentially pivotal studyKarnofsky performance status scaleOverall survivalData safety monitoring boardFast track designationOrphan drug designation

CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy

CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaSandra silbermanJenene thomasSociety of neurooncologyCompany on twitterUniversity of texas md anderson cancer centerExchange commissionPharmaceuticals incSecurities exchangePharmaceuticals fast track designation for berubicinReata pharmaceuticals incGlioblastoma multiformeAnnual meetingChief medical officerInterim results